Jaguar Health, Inc. announced that Pravin Chaturvedi, PhD, a pharmaceutical veteran and leading clinical development expert, has been appointed Chief Scientific Officer and Chair of the Scientific Advisory Board of Jaguar. Prior to this appointment, Dr. Chaturvedi served as Chair of the company's SAB and Acting CSO of Jaguar and Napo Pharmaceuticals (Napo), Jaguar's wholly owned subsidiary.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.385 USD | +8.81% | -43.40% | -52.11% |
07:06pm | Jaguar Health Expands Out-licensing Agreement With Magdalena Biosciences | MT |
17/05 | Jaguar Health Plans 1-for-60 Reverse Split Next Week | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-52.11% | 1.97Cr | |
+8.55% | 12TCr | |
+9.82% | 10TCr | |
-12.02% | 2.27TCr | |
+2.21% | 2.18TCr | |
-10.88% | 1.82TCr | |
-41.90% | 1.65TCr | |
-16.68% | 1.6TCr | |
+1.87% | 1.41TCr | |
+21.29% | 1.07TCr |
- Stock Market
- Equities
- JAGX Stock
- News Jaguar Health, Inc.
- Jaguar Health, Inc. Announces Appointment of Pravin Chaturvedi as Chief Scientific Officer and Chair of the Scientific Advisory Board